JAK1 and particularly JAK3 showed overexpression in the skin of vitiligo patients compared with the controls, with a gradual shift from nonlesional to perilesional and lesional sections, with no correlation between the expression levels of JAK1 and JAK3 and disease activity or severity. This evidence concerns the gene JAK3 and vitiligo.